视网膜激光光凝术（局灶性/格栅样光凝）
眼科项目
≈ ¥800-2500
(≈ $110-350)
大约15-30分钟
免责声明：本站为医疗服务机构，页面信息部分由AI协助制作。健康相关信息不构成医疗建议。如有任何疑问，请咨询医疗专业人士。详情见免责声明
项目介绍
视网膜激光光凝术（局灶性/格栅样光凝）在一般公立医院参考费用约¥560-2000，三甲医院参考费用约¥800-2500，常用于相关诊断评估与就医安排，费用随医院及地区有所差异。
主要用途
Primary clinical uses include: 1) Treatment of diabetic macular edema (DME) — focal photocoagulation for discrete leaking microaneurysms and grid photocoagulation for diffuse edema; 2) Management of branch retinal vein occlusion (BRVO)-associated macular edema; 3) Stabilization of non-proliferative diabetic retinopathy (NPDR) to prevent progression; 4) Adjunctive therapy in select cases of retinal capillary hemangiomas or Coats’ disease; 5) Prevention of vision loss when anti-VEGF therapy is contraindicated, unavailable, or suboptimally responsive.
正常值范围
Retinal laser photocoagulation (focal/grid) is a therapeutic procedure, not a diagnostic test with quantitative laboratory values; therefore, there is no 'normal range' of numerical measurements. Clinical success is assessed qualitatively via ophthalmoscopic evaluation: absence of active leakage on fluorescein angiography (FA), resolution of macular edema on optical coherence tomography (OCT), stable or improved visual acuity (e.g., ≥20/40 Snellen), and absence of new hemorrhages or neovascularization.
偏低可能原因
Inadequate treatment response may manifest as persistent edema or leakage — causes include: 1) Subtherapeutic laser energy/duration, 2) Incomplete coverage of leaking microaneurysms (focal) or edematous areas (grid), 3) Progressive underlying disease (e.g., uncontrolled diabetes, hypertension), 4) Concomitant conditions impairing healing (e.g., renal failure, anemia), 5) Early post-procedure timing before biological effect fully manifests (typically 3–6 weeks).
偏高可能原因
Excessive or inappropriate treatment effects — causes include: 1) Overly intense or confluent laser burns causing retinal scarring or atrophy, 2) Accidental foveal involvement leading to central vision loss, 3) Excessive treatment area triggering paradoxical inflammation or cystoid macular edema, 4) Pre-existing advanced retinopathy with poor tissue tolerance, 5) Laser-induced choroidal neovascularization (rare but reported in chronic cases).